Receptor-mediated endocytosis (RME) is believed to be a major pathway for accessibility of microparticulates to their intracellular site of action. RME is controlled by polymerization of the protein clathrin at the plasma membrane to form coated vesicles, which have been implicated in cellular uptake of both liposome-encapsulated drugs and DNA for gene therapy. The goal of this proposal is to characterize the involvement of RME in microparticulate accessibility and to define further the intracellular roles of RME-related membrane transport pathways. An additional goal of this proposal is to compare microparticulate uptake in non-muscle and muscle cells, as studies of DNA uptake have suggested that differentiated muscle may have specialized uptake pathways. In concert with this last goal, we will explore the cellular function of a novel muscle-specific protein, with similarities to clathrin, that may be involved in a tissue-specific variation of RME. Previous studies funded by this center shave led us to a detailed understanding of the structure of the clathrin molecule, which we can now exploit to study its function and to study the structure and function of related molecules.
The specific aims of this proposal are to 1-Express a dominant negative mutant form of clathrin in a variety of cell types to study specialized clathrin functions including liposome uptake, secretory granule formation, receptor targeting and sorting in epithelial cells; 2-Characterize the biochemical and functional properties of the novel muscle clathrin; 3-Analyze the roles of conventional clathrin and the novel muscle-specific clathrin in muscle cells with respect to endocytosis, DNA uptake and muscle differentiation. It is anticipated that these studies will reveal molecular mechanisms of microparticulate uptake that will help design strategies to increase accessibility of liposomes and DNA to the endocytic pathway. This work will also elucidate the function of clathrin and related molecules in specialized intracellular pathways in a variety of cell types.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM057657-03
Application #
6019428
Study Section
Special Emphasis Panel (ZGM1-PS-5 (01))
Project Start
1997-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Towler, Mhairi C; Gleeson, Paul A; Hoshino, Sachiko et al. (2004) Clathrin isoform CHC22, a component of neuromuscular and myotendinous junctions, binds sorting nexin 5 and has increased expression during myogenesis and muscle regeneration. Mol Biol Cell 15:3181-95
Towler, Mhairi C; Kaufman, Stephen J; Brodsky, Frances M (2004) Membrane traffic in skeletal muscle. Traffic 5:129-39
Molinete, M; Dupuis, S; Brodsky, F M et al. (2001) Role of clathrin in the regulated secretory pathway of pancreatic beta-cells. J Cell Sci 114:3059-66
Brodsky, F M; Chen, C Y; Knuehl, C et al. (2001) Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell Dev Biol 17:517-68
Liu, S H; Towler, M C; Chen, E et al. (2001) A novel clathrin homolog that co-distributes with cytoskeletal components functions in the trans-Golgi network. EMBO J 20:272-84
Bennett, E M; Chen, C Y; Engqvist-Goldstein, A E et al. (2001) Clathrin hub expression dissociates the actin-binding protein Hip1R from coated pits and disrupts their alignment with the actin cytoskeleton. Traffic 2:851-8
Bennett, E M; Lin, S X; Towler, M C et al. (2001) Clathrin hub expression affects early endosome distribution with minimal impact on receptor sorting and recycling. Mol Biol Cell 12:2790-9
Greene, B; Liu, S H; Wilde, A et al. (2000) Complete reconstitution of clathrin basket formation with recombinant protein fragments: adaptor control of clathrin self-assembly. Traffic 1:69-75
Bennett, E M; Bennink, J R; Yewdell, J W et al. (1999) Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 162:5049-52
Brodsky, F M; Lem, L; Solache, A et al. (1999) Human pathogen subversion of antigen presentation. Immunol Rev 168:199-215

Showing the most recent 10 out of 13 publications